Median Technologies
Created in 2002
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
904 9,022Activities
Technologies
Entity types
Location
06560 Valbonne, France
Valbonne
France
Employees
Scale: 201-500
Estimated: 233
SIREN
443676309Engaged corporates
25
10 10Added in Motherbase
6 years, 2 months ago
biotech Value proposition
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonisTM, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME).
clinical trials, imaging CRO, oncology clinical trials, iRECIST, RECIST 1.1, iBiopsy, Artificial Intelligence, Deep Learning, Big Data, Cloud Computing, Immuno-oncology, Liver diseases, Image processing, Software as Medical Device, Data Science, eyonis, and Medical image processingOriginal language
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonisTM, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME).
Home - Median Technologies
https://mediantechnologies.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 29 Nov 2017 | | |
 Crédit Mutuel Arkéa Bank, Banking | Crédit Mutuel Arkéa Bank, Banking | Not capitalistic Not partnership Event 12 Feb 2020 | | |
 Invest in Côte d'Azur - Team Nice Côte d'Azur Startup accelerator & VC, International Trade and Development | Invest in Côte d'Azur - Team Nice Côte d'Azur Startup accelerator & VC, International Trade and Development | Other 13 Dec 2022 13 Dec 2022 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Not capitalistic Not partnership Event 13 Oct 2021 8 Mar 2024 | | |
 Sophia Antipolis IT Services and IT Consulting | Sophia Antipolis IT Services and IT Consulting | Not capitalistic Not partnership Event 10 Feb 2021 10 Nov 2024 | | |